Esperion Therapeutics adopts 2022 Stock Option and Incentive Plan
Esperion Therapeutics filed its 2022 Stock Option and Incentive Plan to encourage employee ownership through equity awards including options, RSUs, and restricted stock. The plan is designed to align employee interests with shareholder value creation across officers, employees, directors, and consultants.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day